Delivery Order SPE2DB22D1052-SPE2DB25FU9FE
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,754.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lyrica 75 mg capsules and has a period of performance through March 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 75 mg capsules. The contract has a ceiling value of $1,923.45 and a period of performance through May 1, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which does not have a set-aside designation, is for the delivery of LYRICA 75 MG CAPSULE 90S, with a potential value of $6,071.69 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a potential value...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $1,091.58, is for the delivery of Lyrica 75 mg capsules to support military treatment programs and facilities. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company holds an...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of LYRICA 75 MG CAPSULE 90S, with a completion date of February 14, 2024 and a potential value of $5,123.83. Amerisourcebergen Drug Corp is the prime contractor and serves as the primary contract vehicle for the company to deliver...
This is a $3,388.07 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LYRICA 150 mg capsules. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical to provide a range of medical commodities to support...
This is a $31,178.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Lyrica 150 mg capsules to support federal healthcare programs and facilities. The order has a performance period ending on September 12, 2024. This award is part of a larger indefinite-delivery/indefinite-quantity (IDIQ) contract valued at up to $999,999,999 held by AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,236.86 contract is for the delivery of LYRICA 75 MG CAPSULE 90S, a prescription medication, to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a $12,371.13 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LYRICA 25 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.82, is for the delivery of 4,567,860,790 units of Lyrica 75 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...